MiMedx Group (MDXG) Projected to Post Earnings on Wednesday

MiMedx Group (NASDAQ:MDXG) is anticipated to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $89.42 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

MiMedx Group Stock Performance

Shares of NASDAQ MDXG opened at $8.22 on Wednesday. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10. The business’s 50 day moving average is $8.92 and its two-hundred day moving average is $7.62. The company has a market cap of $1.21 billion, a P/E ratio of 14.95 and a beta of 1.94. MiMedx Group has a 12 month low of $5.47 and a 12 month high of $10.14.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.